Literature DB >> 22609162

Serum biomarker in neurofibromatosis type 1.

Yuichi Yoshida, Minao Furumura, Makoto Tahira, Takashi Horie, Osamu Yamamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22609162     DOI： 10.1016/j.jdermsci.2012.04.010

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN： 0923-1811            Impact factor:   4.563


× No keyword cloud information.
  5 in total

1.  The expression of melanoma inhibitory activity on mast cells in child patients with cutaneous mastocytosis.

Authors:  Yuko Ehara; Yuichi Yoshida; Makoto Tahira; Osamu Yamamoto
Journal:  Yonago Acta Med       Date:  2014-10-15       Impact factor: 1.641

2.  Increased serum concentrations of estrogen-induced growth factors Midkine and FGF2 in NF1 patients with plexiform neurofibroma.

Authors:  Isis Atallah; Ana M Cieza Rivera; Octavio M Rivero Lezcano; Laura Tascón-González; Carolina González-Cortés; Cristina Diez Tascón; Tania Fernández-Villa; Vicente Martín
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

3.  Current status and recommendations for biomarkers and biobanking in neurofibromatosis.

Authors:  C Oliver Hanemann; Jaishri O Blakeley; Fabio P Nunes; Kent Robertson; Anat Stemmer-Rachamimov; Victor Mautner; Andreas Kurtz; Michael Ferguson; Brigitte C Widemann; D Gareth Evans; Rosalie Ferner; Steven L Carroll; Bruce Korf; Pierre Wolkenstein; Pamela Knight; Scott R Plotkin
Journal:  Neurology       Date:  2016-08-16       Impact factor: 9.910

Review 4.  Circulating tumor DNA for malignant peripheral nerve sheath tumors in neurofibromatosis type 1.

Authors:  Jordan Jones; Sarah Cain; Jonathan Pesic-Smith; Peter F M Choong; Andrew P Morokoff; Kate J Drummond; Gabriel Dabscheck
Journal:  J Neurooncol       Date:  2021-09-16       Impact factor: 4.130

5.  Effector T cell subclasses associate with tumor burden in neurofibromatosis type 1 patients.

Authors:  Said Farschtschi; Su-Jin Park; Birgit Sawitzki; Su-Jun Oh; Lan Kluwe; Victor F Mautner; Andreas Kurtz
Journal:  Cancer Immunol Immunother       Date:  2016-07-23       Impact factor: 6.968
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.